A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
Clinical trial NCT05889988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05889988
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-12
- Primary completion
- 2027-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.